Related Experiment Videos
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors
A Novogrodsky1, A Vanichkin, M Patya
1Felsenstein Medical Research Center, Petach Tikva, Israel.
Abstract:
Septic shock results from excessive stimulation of the host immune system, especially macrophages, by lipopolysaccharide (LPS), or endotoxin, which resides on the outer membrane of bacteria. Protein tyrosine kinase inhibitors of the tyrphostin AG 126 family protect mice against LPS-induced lethal toxicity. The protection correlates with the ability of these agents to block LPS-induced production of tumor necrosis factor alpha (TNF-alpha) and nitric oxide in macrophages as well as LPS-induced production of TNF-alpha in vivo. Furthermore, this inhibitory effect correlated with the potency of AG 126 to block LPS-induced tyrosine phosphorylation of a p42MAPK protein substrate in the murine macrophage.
Insights
Tyrphostin AG 126 inhibitors protect mice from septic shock by blocking lipopolysaccharide (LPS) effects. These inhibitors reduce harmful inflammatory molecules like tumor necrosis factor alpha (TNF-alpha) and nitric oxide.
Area of Science:
- Immunology
- Pharmacology
Background:
- Septic shock is a life-threatening condition caused by excessive immune system activation, particularly in macrophages, due to bacterial lipopolysaccharide (LPS).
- Lipopolysaccharide (LPS), also known as endotoxin, is a component of bacterial outer membranes that triggers potent immune responses.
Purpose of the Study:
- To investigate the protective effects of protein tyrosine kinase inhibitors, specifically the tyrphostin AG 126 family, against LPS-induced septic shock.
- To determine the correlation between the inhibitory action of AG 126 and its effects on inflammatory mediator production and cellular signaling pathways.
Main Methods:
- Mice were treated with tyrphostin AG 126 and subsequently exposed to LPS to assess survival rates.
- Macrophage cultures were stimulated with LPS to measure the production of tumor necrosis factor alpha (TNF-alpha) and nitric oxide.
- Tyrosine phosphorylation of p42MAPK in macrophages was analyzed following LPS stimulation and AG 126 treatment.
Main Results:
- Tyrphostin AG 126 administration significantly protected mice against lethal LPS toxicity.
- AG 126 inhibited LPS-induced production of TNF-alpha and nitric oxide in macrophages.
- The protective effect of AG 126 correlated with its ability to block LPS-induced tyrosine phosphorylation of p42MAPK in macrophages.
Conclusions:
- Protein tyrosine kinase inhibitors of the tyrphostin AG 126 family demonstrate significant efficacy in preventing LPS-induced septic shock.
- AG 126 exerts its protective effects by modulating key inflammatory pathways, including the inhibition of TNF-alpha, nitric oxide, and p42MAPK phosphorylation.